Table 1.
Dose Modifications During Induction Therapy
| Dose Level |
Idarubicin (mg/m2/d × 3) |
Cytarabine (g/m2/24 h × 3-4) days |
Tipifarnib (mg PO BID × 21 d every course) |
|---|---|---|---|
| 0 | 12 | 1.5 | 300 |
| −1 | 8 | 1.0 | 200 |
| −2 | 6 | 0.75 | 100 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.